November 11, 2025

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Navigating 39.69% Potential Upside Amidst Transformative Drug Discovery

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) stands at an intriguing crossroads, offering a potential upside of nearly 39.69% based on its average target price of $6.30. As..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Navigating a 30.69% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a prominent player in the biopharmaceutical space, specializes in developing and commercializing treatments for central nervous system (CNS) diseases. Although the..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 33% Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is carving out a significant niche in the U.S. healthcare sector with its comprehensive suite of outpatient mental health services...

Merus N.V. (MRUS): Investor Outlook on a Promising Biotechnology Contender with a 1.66% Upside Potential

Merus N.V. (NASDAQ: MRUS), a Netherlands-based biotechnology firm, is increasingly capturing the attention of investors, particularly those with a keen eye on the healthcare sector. With..

Zai Lab Limited (ZLAB) Investor Outlook: Navigating a 132% Potential Upside in the Biotech Sector

Zai Lab Limited (NASDAQ: ZLAB), a prominent player in the biotechnology sector, is capturing investor attention with an enticing potential upside of 132.25%. This Chinese biopharmaceutical..

ICU Medical, Inc. (ICUI) Stock Analysis: Potential Upside Amidst Strong Analyst Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a prominent player in the medical instruments and supplies industry, offers a compelling investment proposition with its focus on infusion therapy,..

Progyny, Inc. (PGNY) Stock Analysis: 20.66% Potential Upside Beckons Investors in Fertility Benefits Market

Progyny, Inc. (NASDAQ: PGNY), a leader in fertility and family-building benefits solutions, is creating quite a buzz in the healthcare sector, particularly among investors keen on..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 119% Potential Upside Amidst Market Challenges

NovoCure Limited (NASDAQ: NVCR), a prominent player in the healthcare sector, specifically within the medical devices industry, offers a portfolio focused on innovative oncology solutions. The..

Viking Therapeutics, Inc. (VKTX) Investor Outlook: Exploring a Potential 147% Upside in the Biotech Sector

Viking Therapeutics, Inc. (NASDAQ: VKTX) has caught the eye of investors, thanks in part to its substantial potential upside of 147.11%, according to recent analyst ratings...

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: Exploring a Strong 19.2% Upside Potential

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is capturing the attention of investors with its promising 19.2% upside potential, underpinned by a robust pipeline and strategic collaborations. As..

Arcellx, Inc. (ACLX) Stock Analysis: 32% Potential Upside Amidst Biotech Innovations

Arcellx, Inc. (NASDAQ: ACLX) is steadily carving out a niche in the rapidly evolving biotechnology sector. Headquartered in Redwood City, California, Arcellx is engaged in the..

Apogee Therapeutics, Inc. (APGE) Stock Analysis: A Promising 70% Potential Upside in the Biotech Sector

Apogee Therapeutics, Inc. (NASDAQ: APGE) appears to be a rising star in the biotechnology sector, with a market capitalization of $3.88 billion and a compelling narrative..

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Navigating a 7.52% Upside Potential Amidst Biotech Breakthroughs

PTC Therapeutics, Inc. (NASDAQ: PTCT), a key player in the biotechnology sector, has been making waves in the healthcare industry with its focus on rare disorders...

Harmony Biosciences Holdings (HRMY) Stock Analysis: A Biotech Gem with 39.99% Potential Upside

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY) represents an intriguing opportunity within the biotechnology sector for investors looking to gain exposure to a company with a promising..

CRISPR Therapeutics AG (CRSP)

⚠️ No article content returned.

..

CG Oncology, Inc. (CGON) Stock Analysis: A Promising Biotech with 69% Upside Potential

Investors looking for promising opportunities in the biotechnology sector should pay close attention to CG Oncology, Inc. (NASDAQ: CGON). With a market capitalization of $3.07 billion..

Addus HomeCare Corporation (ADUS) Stock Analysis: Exploring a 27% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS) is garnering attention within the healthcare sector, primarily due to its robust growth trajectory and promising upside potential reflected in recent..

Acadia Healthcare Company, Inc. (ACHC) Stock Analysis: Unlocking a 48% Potential Upside

Acadia Healthcare Company, Inc. (NASDAQ: ACHC), a prominent player in the healthcare sector, particularly in the medical care facilities industry, is capturing the attention of investors..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A Biotech Contender with 36% Upside Potential

MoonLake Immunotherapeutics (MLTX), a clinical-stage biotechnology firm based in Zug, Switzerland, is making waves in the healthcare sector with its innovative approach to treating inflammatory skin..

Denali Therapeutics Inc. (DNLI) Stock Analysis: Unpacking the 102.56% Potential Upside

Denali Therapeutics Inc. (NASDAQ: DNLI) stands at the forefront of biopharmaceutical innovation, developing groundbreaking therapeutics for neurodegenerative and lysosomal storage diseases. With a market capitalization of..

Search

Funds

November 11, 2025

Search

Funds

November 11, 2025

FTSE 100

Funds